Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for Novo Nordisk Canada Inc.

Iain Graham, General Manager (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 140

  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2026-04-08
    Posted date: 2026-05-15
    Communication number: 360616-678264 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Roy Karam, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2026-03-26
    Posted date: 2026-04-15
    Communication number: 360616-675508 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michael Coteau, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2026-03-24
    Posted date: 2026-04-15
    Communication number: 360616-675583 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nasser Haidar, Senior Policy Advisor | Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Intergovernmental Affairs Secretariat (IGA)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2026-03-23
    Posted date: 2026-04-15
    Communication number: 360616-676258 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jacques Ramsay, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2026-03-17
    Posted date: 2026-04-15
    Communication number: 360616-675116 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Marjorie Michel, Minister of Health | Health Canada (HC)
    • Justine Frame, Special Assistant, Policy | Office of the Minister of Health | Health Canada (HC)
    • Shalene Curtis-Micallef, Deputy Minister, Health | Health Canada (HC)
    • Martin Moen, Deputy Minister, Trade Policy and Negotiations | Global Affairs Canada (GAC)
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)
    • Karim Bardeesy, Member of Parliament | House of Commons
    • Janice Charette, Chief Trade Negotiator to the United States | Privy Council Office (PCO)
    • Nasser Haidar, Senior Policy Advisor | Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Intergovernmental Affairs Secretariat (IGA)
    • Dominic LeBlanc, President of the King's Privy Council for Canada and Minister of International Trade and Intergovernmental Affairs | House of Commons
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2026-02-23
    Posted date: 2026-03-23
    Communication number: 360616-675181 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcus Powlowski, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2026-02-23
    Posted date: 2026-03-16
    Communication number: 360616-670443 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcus Powlowski, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2026-02-10
    Posted date: 2026-03-16
    Communication number: 360616-670204 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2026-02-10
    Posted date: 2026-03-16
    Communication number: 360616-670201 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nora Draper, Parliamentary Secretary Assistant | Office of the Minister of Health | Health Canada (HC)
    • Maggie Chi, Parliamentary Secretary to the Minister of Health | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2026-02-04
    Posted date: 2026-02-11
    Communication number: 360616-668241 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elizabeth Wong, Senior Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)
    • Annahat Kochhar, Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2026-02-02
    Posted date: 2026-03-16
    Communication number: 360616-668239 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Justine Frame, Special Assistant, Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-12-02
    Posted date: 2026-01-15
    Communication number: 360616-659256 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karim Bardeesy, Parliamentary Secretary to the Minister of Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-12-02
    Posted date: 2026-01-15
    Communication number: 360616-659255 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pamela Aung-Thin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Sarah Lawley, Assistant Deputy Minister, | Health Policy Branch | Health Canada (HC)
    • Greg Orencsak, Deputy Minister | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-12-01
    Posted date: 2026-01-15
    Communication number: 360616-659254 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-12-01
    Posted date: 2026-01-15
    Communication number: 360616-659253 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shahad Khalladi, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-11-21
    Posted date: 2025-12-15
    Communication number: 360616-658450 (amended from 360616-658448) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Parm Bains, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2025-11-20
    Posted date: 2025-12-15
    Communication number: 360616-658449 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ali Ehsassi, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-10-23
    Posted date: 2025-11-15
    Communication number: 360616-652369 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Strauss, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-10-21
    Posted date: 2025-11-18
    Communication number: 360616-657956 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-10-21
    Posted date: 2025-11-18
    Communication number: 360616-657955 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daryl Fridhandler, Senator | Senate of Canada

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-10-21
    Posted date: 2025-11-18
    Communication number: 360616-657954 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade, Science and Technology, Research and Development
    Communication date: 2025-10-21
    Posted date: 2025-11-18
    Communication number: 360616-657953 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sonia Sidhu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-10-07
    Posted date: 2025-11-15
    Communication number: 360616-648459 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Dan Mazier, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-09-29
    Posted date: 2025-10-15
    Communication number: 360616-647712 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Galen Richardson, Senior Advisor, Stakeholder Relations | Office of the President of the King's Privy Council for Canada, Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian | Privy Council Office (PCO)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-09-26
    Posted date: 2025-10-15
    Communication number: 360616-647620 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lisa Xie, Policy Advisor | Office of the Minister of Industry | Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic, Senior Policy | Office of the Minister of Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2025-09-11
    Posted date: 2025-10-15
    Communication number: 360616-646318 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mackenzy Metcalfe, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-09-03
    Posted date: 2025-10-15
    Communication number: 360616-644752 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karim Bardeesy, Parliamentary Secretary to the Minister of Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2025-08-28
    Posted date: 2025-09-15
    Communication number: 360616-644751 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matthew Hall, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-08-14
    Posted date: 2025-09-15
    Communication number: 360616-642986 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-08-13
    Posted date: 2025-09-15
    Communication number: 360616-642983 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Director of Policy | Minister's Office | Health Canada (HC)
    • Shahad Khallidi, Deputy Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-07-23
    Posted date: 2025-08-15
    Communication number: 360616-642533 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lesley Sherban, Chief of Staff | Office of the Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-04-01
    Posted date: 2025-05-15
    Communication number: 360616-634112 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tania Belisle-Leclerc, Director of Policy | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-03-24
    Posted date: 2025-04-15
    Communication number: 360616-634017 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2025-01-29
    Posted date: 2025-02-15
    Communication number: 360616-630151 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Linsey Hollett, Assistant Deputy Minister | Regulatory, Operations and Enforcement Branch | Health Canada (HC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2024-10-08
    Posted date: 2024-11-15
    Communication number: 360616-616482 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Tannas, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-10-02
    Posted date: 2024-11-15
    Communication number: 360616-616480 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ya'ara Saks, Minister of Mental Health and Addictions, Associate Minister of Health | Health Canada (HC)
    • Michelle Boudreau, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 360616-616710 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 360616-616707 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 360616-616706 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Bannerjee, Assistant Deputy Minister | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 360616-616705 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Chris Zhou, Director of Policy (Acting) | Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Christiana Osei, Digital Media and Communications Advisor | Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Ajay Rakhra, Senior Advisor, Ontario and Stakeholder Relations | Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 360616-616704 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Chambers, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 360616-616703 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-08-08
    Posted date: 2024-09-16
    Communication number: 360616-612250 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matthew Trnkus, Policy Advisor | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2024-07-22
    Posted date: 2024-08-15
    Communication number: 360616-611661 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andrew Cardozo, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-07-17
    Posted date: 2024-08-15
    Communication number: 360616-611497 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chelios Vuong, Policy Advisor | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2024-07-15
    Posted date: 2024-08-15
    Communication number: 360616-611033 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jeremy Bruce, Deputy Director, Policy | Office of the Minister of Foreign Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade
    Communication date: 2024-07-09
    Posted date: 2024-08-15
    Communication number: 360616-609919 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-06-05
    Posted date: 2024-07-15
    Communication number: 360616-607097 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | Red Deer—Mountain View | House of Commons
    • Blaine Calkins, Member of Parliament | Red Deer—Lacombe | House of Commons
    • Tom Kmiec, Member of Parliament | Calgary Shepard | House of Commons
    • Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2024-05-23
    Posted date: 2024-06-15
    Communication number: 360616-607098 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sharon Burey, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-03-27
    Posted date: 2024-04-15
    Communication number: 360616-598604 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randy Hoback, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2024-03-19
    Posted date: 2024-04-15
    Communication number: 360616-598440 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jade Mallette, Director of Parliamentary Affairs | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-03-13
    Posted date: 2024-04-15
    Communication number: 360616-597114 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-02-28
    Posted date: 2024-03-15
    Communication number: 360616-595016 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-08
    Posted date: 2024-01-15
    Communication number: 360616-586544 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jwane Izzetpanah, Manager of Stakeholder Relations | House of Commons
    • Connor MacDonald, Policy Advisor | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-15
    Posted date: 2023-12-15
    Communication number: 360616-585155 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2023-11-14
    Posted date: 2023-12-15
    Communication number: 360616-584604 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-Pier Fontaine, Senior Policy Advisor | Deputy Minister's Office | Health Canada (HC)
    • Celia Lourenco, Acting Associate Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Michael Collins, Vice-President | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
    • Nancy Hamzawi, Executive Vice President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2023-11-14
    Posted date: 2023-12-15
    Communication number: 360616-583374 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Zhou, Senior Policy and Atlantic Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Rechie Valdez, Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-15
    Communication number: 360616-585168 (amended from 360616-585153) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jeff Waring, Associate Assistant Secretary | Privy Council Office (PCO)
    • Jennifer Miller, Assistant Secretary | Privy Council Office (PCO)

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-15
    Communication number: 360616-585151 (amended from 360616-585150) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-15
    Communication number: 360616-584071 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Theriault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-11-15
    Communication number: 360616-584068 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-15
    Communication number: 360616-585162 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-15
    Communication number: 360616-584064 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-15
    Communication number: 360616-584059 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chelsea Madryga, Policy Advisor | Office of the Minister of Health | Health Canada (HC)
    • Eshan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-10-13
    Posted date: 2023-11-15
    Communication number: 360616-579538 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Danna Campbell, Director, Partnerships & Strategies | Health Promotion and Chronic Disease Prevention Branch | Health Canada (HC)
    • David Luchuk, A/Director | Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division | Public Health Agency of Canada (PHAC)
    • Michael Collins, A/Vice-President | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2023-09-19
    Posted date: 2023-10-16
    Communication number: 360616-577177 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-05-29
    Posted date: 2023-06-15
    Communication number: 360616-566944 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2023-05-04
    Posted date: 2023-06-15
    Communication number: 360616-564219 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Michael Collins, A/ Associate Deputy Minister | Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2023-05-03
    Posted date: 2023-06-15
    Communication number: 360616-564217 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Deputy Director of Policy | Minister's Office | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Office of the Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-04-12
    Posted date: 2023-05-15
    Communication number: 360616-561897 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Razan Shahin, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2023-03-29
    Posted date: 2023-04-15
    Communication number: 360616-560744 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Andy Fillmore, Parliamentary Secretary to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    • Sarah MacDonald, Special Assistant (Assistant to the Parliamentary Secretary and Parliamentary Affairs) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2023-03-27
    Posted date: 2023-04-15
    Communication number: 360616-560640 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chelsea Madryga, Parliamentary Secretary Assistant | Health Canada (HC)
    • Adam van Koeverden , Parliamentary Secretary | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-21
    Posted date: 2023-04-15
    Communication number: 360616-560456 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Policy Advisor | Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2023-03-06
    Posted date: 2023-04-15
    Communication number: 360616-557753 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2023-02-16
    Posted date: 2023-03-15
    Communication number: 360616-557037 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • An Brian A Huynh, Junior Policy Analyst | Social Development Policy | Employment and Social Development Canada (ESDC)
    • Erin Krzyzanowski, Manager | Social Development Policy | Employment and Social Development Canada (ESDC)
    • Kaitlin Blackhall, Manager | Strategic Policy | Employment and Social Development Canada (ESDC)
    • Marebame Longe, Manager | Strategic Policy | Employment and Social Development Canada (ESDC)
    • Poppy Vineberg, Director | Strategic Horizontal Social Policy | Employment and Social Development Canada (ESDC)
    • Jason Baillargeon, Director | Food Policy Division | Agriculture and Agri-Food Canada (AAFC)
    • Patrick Verreault, Deputy Director | Food Policy Division | Agriculture and Agri-Food Canada (AAFC)

    Subject Matter of the communication: Health
    Communication date: 2023-02-10
    Posted date: 2023-02-15
    Communication number: 360616-556448 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam van Koeverden, , Parliamentary Secretary to the Minister of Health and to the Minister of Sport | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-12-13
    Posted date: 2022-12-15
    Communication number: 360616-551769 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Luchuk, Manager | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    • Annie Comtois, Acting Executive Director | EXECUTIVE DIRECTOR OFFICE BUREAU DE LA DIRECTRICE EXÉCUTIVE EDO-BDE | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2022-11-25
    Posted date: 2022-12-15
    Communication number: 360616-551750 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tasha Stefanis, Associate Vice President | Health Promotion and Chronic Disease Prevention | Public Health Agency of Canada (PHAC)
    • Pamela Turpin, Manager | Public Health Agency of Canada (PHAC)
    • Annie Comtois, Director, Programs and Performance | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    • Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2022-09-26
    Posted date: 2022-12-15
    Communication number: 360616-551859 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nathanielle Morin, Policy Advisor | Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-08-30
    Posted date: 2022-12-15
    Communication number: 360616-551874 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2022-07-21
    Posted date: 2022-12-15
    Communication number: 360616-551851 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Patrick Delorme, Policy Analyst | PHAC | Public Health Agency of Canada (PHAC)
    • Nolan D’Souza, Program/Policy Fellow | PHAC | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-25
    Posted date: 2022-12-15
    Communication number: 360616-551845 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathy Thompson, Executive Vice-President of the Public Health Agency of Canada | PHAC | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-05
    Posted date: 2022-12-15
    Communication number: 360616-551843 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Van Koeverden, Member of Parliament | Parliamentary Secretary to the Minister of Health and Sport | House of Commons
    • Heather Jeffrey, Associate Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-04
    Posted date: 2022-12-15
    Communication number: 360616-552263 (amended from 360616-551831) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-03-15
    Posted date: 2022-12-15
    Communication number: 360616-551788 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michael Barrett, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-03-10
    Posted date: 2022-03-10
    Communication number: 360616-524796 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lindsay Mathyssen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-02-28
    Posted date: 2022-03-09
    Communication number: 360616-524604 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-02-28
    Posted date: 2022-03-09
    Communication number: 360616-524599 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nathanielle Morin, Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-02-25
    Posted date: 2022-03-09
    Communication number: 360616-524594 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rebecca Caldwell, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2022-02-22
    Posted date: 2022-03-09
    Communication number: 360616-523631 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ziad Aboultaif, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-02-15
    Posted date: 2022-03-09
    Communication number: 360616-523595 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris d'Entremont, Member of Pariament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-11-23
    Posted date: 2021-12-15
    Communication number: 360616-516121 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sonia Sidhu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-11-05
    Posted date: 2021-11-16
    Communication number: 360616-516015 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-France Lalonde, Member of Parliament | Orléans | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-04-01
    Posted date: 2021-05-15
    Communication number: 360616-500466 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-France Lalonde, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-03-22
    Posted date: 2021-04-15
    Communication number: 360616-500123 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Aitchison, Member of Parliament | Parry Sound—Muskoka | House of Commons

    Subject Matter of the communication: Arts and Culture, Health
    Communication date: 2021-02-08
    Posted date: 2021-03-15
    Communication number: 360616-494594 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sonia Sidhu, Member of Parliament | Brampton South | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2021-01-18
    Posted date: 2021-02-15
    Communication number: 360616-493912 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris D'Entremont, Member of Parliament | West Nova | House of Commons

    Subject Matter of the communication: Arts and Culture, Health, Research and Development
    Communication date: 2020-10-29
    Posted date: 2020-11-16
    Communication number: 360616-485814 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | Markham—Stouffville | House of Commons

    Subject Matter of the communication: Arts and Culture, Health, Science and Technology
    Communication date: 2020-10-26
    Posted date: 2020-11-16
    Communication number: 360616-485816 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ali Ehsassi, Parliamentary Secretary | Innovation and Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Arts and Culture, Research and Development
    Communication date: 2020-10-20
    Posted date: 2020-11-16
    Communication number: 360616-485585 (amended from 360616-485584) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Arts and Culture, Health, Research and Development
    Communication date: 2020-10-16
    Posted date: 2020-11-16
    Communication number: 360616-485815 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Special Assistant, Policy and Assistant to the Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Arts and Culture, Science and Technology
    Communication date: 2020-09-14
    Posted date: 2020-10-15
    Communication number: 360616-481823 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • William Amos, Member of Parliament | House of Commons

    Subject Matter of the communication: Arts and Culture, Health, Industry, Science and Technology
    Communication date: 2020-09-11
    Posted date: 2020-10-15
    Communication number: 360616-481820 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christine Loth-Bown, Vice-President | Indigenous Affairs and Cultural Heritage Directorate | Parks Canada (PC)

    Subject Matter of the communication: Arts and Culture
    Communication date: 2020-08-31
    Posted date: 2021-07-14
    Communication number: 360616-510412 (amended from 360616-481813) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sonia Sidhu, Member of Parliament | House of Commons

    Subject Matter of the communication: Arts and Culture, Health, Research and Development
    Communication date: 2020-07-17
    Posted date: 2020-08-15
    Communication number: 360616-478477 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Janet McPhee, Senior Investment Officer | Global Affairs Canada (GAC)
    • Zoe Hawa, Deputy Director, Life Sciences | Global Affairs Canada (GAC)
    • Louise Rousseau, Deputy Director - Geographic (Europe) | Global Affairs Canada (GAC)

    Subject Matter of the communication: Employment and Training, Health, Industry, Science and Technology, Research and Development, Economic Development
    Communication date: 2019-02-26
    Posted date: 2019-03-15
    Communication number: 360616-447035 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Arthur Lam, Senior Advisor | Small Business Minister's Office and Export Promotion | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Employment and Training, Health, Industry, Internal Trade, Economic Development
    Communication date: 2019-02-26
    Posted date: 2019-03-15
    Communication number: 360616-447034 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Emily Yorke, Senior Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Regional Development, Economic Development
    Communication date: 2019-02-26
    Posted date: 2019-03-15
    Communication number: 360616-447030 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Economic Development
    Communication date: 2019-02-20
    Posted date: 2019-03-15
    Communication number: 360616-447033 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons

    Subject Matter of the communication: Employment and Training, Health, Industry, Economic Development
    Communication date: 2019-02-11
    Posted date: 2019-03-15
    Communication number: 360616-447032 (amended from 360616-447031) View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology, Research and Development, Economic Development
    Communication date: 2019-01-30
    Posted date: 2019-02-15
    Communication number: 360616-444411 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2019-01-22
    Posted date: 2019-02-15
    Communication number: 360616-444410 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | LSID | Innovation, Science and Economic Development Canada (ISED)
    • Edward Burrows, Analyst / Economist | LSID | Innovation, Science and Economic Development Canada (ISED)
    • Tereasa Chudy, Economist | LSID | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2019-01-09
    Posted date: 2019-02-04
    Communication number: 360616-444409 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | LSID | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Sr Project Leader | LSID | Innovation, Science and Economic Development Canada (ISED)
    • Jessica Godard, Junior Analyst | LSID | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, International Trade, Science and Technology, International Development, Research and Development, Economic Development
    Communication date: 2018-12-14
    Posted date: 2018-12-17
    Communication number: 360616-442796 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
    • Kathy Kettler, Advisor | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Aboriginal Affairs, Health, International Relations, Regional Development, Economic Development
    Communication date: 2018-12-14
    Posted date: 2018-12-17
    Communication number: 360616-442795 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health, Regional Development, Research and Development, Economic Development
    Communication date: 2018-12-13
    Posted date: 2018-12-17
    Communication number: 360616-442793 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnick, Director | Patented Medicine Prices Review Board (PMPRB)
    • Matthew Kellison, Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-12-11
    Posted date: 2018-12-17
    Communication number: 360616-442783 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
    • Joseph Wabegijig, Policy Advisor | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Aboriginal Affairs, Health, Industry, Research and Development, Economic Development
    Communication date: 2018-11-16
    Posted date: 2018-11-26
    Communication number: 360616-440208 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-11-16
    Posted date: 2018-11-26
    Communication number: 360616-440207 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Sr Project Leader | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology, Research and Development, Economic Development
    Communication date: 2018-11-16
    Posted date: 2018-11-26
    Communication number: 360616-440206 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kate Moussouni, Senior Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2018-11-16
    Posted date: 2018-11-26
    Communication number: 360616-440205 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister | Strategic Policy Branch (SPB) | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Office of the Minister | Health Canada (HC)
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Paul Halucha, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Internal Trade, Science and Technology
    Communication date: 2018-10-05
    Posted date: 2018-10-26
    Communication number: 360616-436555 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gabe Frost, Senior Policy Analyst | Regulatory Review | Treasury Board Of Canada Secretariat (TBS)
    • Rob Turk, Policy Advisor | Food and Agriculture Regulatory Reviews | Treasury Board Of Canada Secretariat (TBS)
    • Christopher Lee, Research Analyst | Regulatory Reviews | Treasury Board Of Canada Secretariat (TBS)
    • Alan Neeff, Director | Regulatory Policy Cooperation | Treasury Board Of Canada Secretariat (TBS)
    • Alexandra Nur, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    • Barn-Yen Li, Senior Advisor | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-08-29
    Posted date: 2018-09-07
    Communication number: 360616-433231 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Research and Development, Economic Development
    Communication date: 2018-08-29
    Posted date: 2018-09-07
    Communication number: 360616-433230 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Oliver, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-08-27
    Posted date: 2018-09-07
    Communication number: 360616-433227 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Research and Development, Economic Development
    Communication date: 2018-08-09
    Posted date: 2018-09-07
    Communication number: 360616-433229 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Senior Policy Analyst | Innovation, Science and Economic Development Canada (ISED)
    • Razan Shahin, Sector Analyst | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-07-18
    Posted date: 2018-09-07
    Communication number: 360616-433228 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    • Elder Marques, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology, Research and Development, Economic Development
    Communication date: 2018-07-12
    Posted date: 2018-09-07
    Communication number: 360616-433226 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Christopher Berzins, Director of Policy | Trade Minister's Office | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-07-12
    Posted date: 2018-09-07
    Communication number: 360616-433225 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shawn Tupper, Assistant Secretary to Cabinet, Economic and Regional Development Policy (Operations) | Privy Council Office (PCO)
    • Marian Campbell Jarvis, Assistant Secretary to the Cabinet, Social Development Policy | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-07-12
    Posted date: 2018-09-07
    Communication number: 360616-433224 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • John Oliver, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Economic Development
    Communication date: 2018-05-08
    Posted date: 2018-09-07
    Communication number: 360616-433223 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Janet MacPhee, A/Director | Global Affairs Canada (GAC)
    • Kim Ryel, Manager, life sciences | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-05-08
    Posted date: 2018-09-07
    Communication number: 360616-433222 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Nancy Nancy Faraday-Smith, A/Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-05-08
    Posted date: 2018-09-07
    Communication number: 360616-433221 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2018-05-08
    Posted date: 2018-09-07
    Communication number: 360616-433220 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bill Morneau, Minister of Finance | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-03-01
    Posted date: 2018-04-16
    Communication number: 360616-420970 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ramez Ayoub, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-02-20
    Posted date: 2018-03-15
    Communication number: 360616-420969 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sonia Sidhu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-02-15
    Posted date: 2018-03-15
    Communication number: 360616-420968 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • David Clemens, Manager, Business Development and Analytics | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2017-12-05
    Posted date: 2018-03-06
    Communication number: 360616-420967 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Shawn Tippins, Policy Analyst, Industry Sector – Life Sciences | Innovation, Science and Economic Development Canada (ISED)
    • Nancy Faraday-Smith, Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2017-12-05
    Posted date: 2018-03-06
    Communication number: 360616-420966 View monthly communication report
  • Novo Nordisk Canada Inc.
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pam Goldsmith Jones, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-12-05
    Posted date: 2018-03-06
    Communication number: 360616-420965 View monthly communication report
Date Modified: